Gross Profit (Annual) Chart

View Gross Profit (Annual) for VERU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Gross Profit (Annual) Data

View and export this data back to 1994. Start Trial.
Date Value
September 30, 2025 -0.1521M
September 30, 2024 -0.2682M
September 30, 2023 7.495M
September 30, 2022 30.52M
September 30, 2021 47.81M
September 30, 2020 30.47M
September 30, 2019 21.35M
September 30, 2018 8.507M
September 30, 2017 6.872M
September 30, 2016 13.36M
September 30, 2015 18.97M
September 30, 2014 13.12M
September 30, 2013 17.50M
September 30, 2012 20.62M
September 30, 2011 9.865M
September 30, 2010 12.92M
Date Value
September 30, 2009 13.52M
September 30, 2008 10.73M
September 30, 2007 7.156M
September 30, 2006 5.489M
September 30, 2005 4.791M
September 30, 2004 3.622M
September 30, 2003 3.589M
September 30, 2002 3.561M
September 30, 2001 2.310M
September 30, 2000 0.5821M
September 30, 1999 0.1167M
September 30, 1998 0.178M
September 30, 1997 0.5407M
September 30, 1996 -0.6704M
September 30, 1995 -0.3793M
September 30, 1994 8.157M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 450.64M
Corcept Therapeutics, Inc. 748.43M
Johnson & Johnson 64.63B
Eli Lilly & Co. 54.13B
Lexicon Pharmaceuticals, Inc. 48.91M